Hubei JXBio Pharmaceutical Co., Ltd. vs Medline Industries, LP: FDA Enforcement Comparison

Medline Industries, LP has been the subject of 242 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Hubei JXBio Pharmaceutical Co., Ltd..

Hubei JXBio Pharmaceutical Co., Ltd.: 0 warning letters, 0 recalls, 0 approval records, 1 Form 483.

Medline Industries, LP: 0 warning letters, 242 recalls, 0 approval records, 0 Form 483s.

Side by side

Hubei JXBio Pharmaceutical Co., Ltd. — Warning letters0

Medline Industries, LP — Warning letters0

Hubei JXBio Pharmaceutical Co., Ltd. — Recalls0

Medline Industries, LP — Recalls242

Hubei JXBio Pharmaceutical Co., Ltd. — Approval records0

Medline Industries, LP — Approval records0

Hubei JXBio Pharmaceutical Co., Ltd. — Form 483s1

Medline Industries, LP — Form 483s0

Timeline

Hubei JXBio Pharmaceutical Co., Ltd.

Most recent FDA action: March 14, 2025

Full history →

Medline Industries, LP

Most recent FDA action: July 1, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Hubei JXBio Pharmaceutical Co., Ltd. vs Medline Industries, LP: FDA Enforcement Comparison." Argus HQ, accessed July 13, 2026. https://argushq.ai/compare/hubei-jxbio-pharmaceutical-co-ltd-vs-medline-industries-lp

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗